share_log

Earnings Call Summary | ORACLE CORP JAPAN(OCLCF.US) Q3 2024 Earnings Conference

Earnings Call Summary | ORACLE CORP JAPAN(OCLCF.US) Q3 2024 Earnings Conference

業績電話會議摘要 | 日本甲骨文公司 (OCLCF.US) 2024 年第三季度業績會議
富途資訊 ·  03/19 17:12  · 電話會議

The following is a summary of the Oracle Corporation Japan (OCLCF) Q3 2024 Earnings Call Transcript:

以下是日本甲骨文公司(OCLCF)2024年第三季度業績電話會議記錄摘要:

Financial Performance:

財務業績:

  • Oracle Japan's total revenue for the first nine months reached JPY 176,883 million, showing an 8.4% growth primarily due to their cloud revenue.

  • Cloud service revenue saw a significant progress, with a 36.3% increase to JPY 35,578 million, representing 20% of the company's overall revenues.

  • Strong momentum was observed in Infrastructure consumption revenues, especially in autonomous database.

  • Both Operating income and net income saw an increase of 9.7%, standing at JPY 57,706 million and JPY 40,181 million respectively.

  • The company saw its highest ever margins in the third quarter.

  • 日本甲骨文公司前九個月的總收入達到1768.83億日元,增長了8.4%,這主要歸因於其雲收入。

  • 雲服務收入取得了重大進展,增長了36.3%,達到355.78億日元,佔公司總收入的20%。

  • 基礎設施消費收入勢頭強勁,尤其是在自治數據庫方面。

  • 營業收入和淨收入均增長了9.7%,分別爲577.06億日元和401.81億日元。

  • 該公司在第三季度創下了有史以來最高的利潤率。

Business Progress:

業務進展:

  • Oracle's cloud business continues to drive the accelerating growth corroborating the company's revenue trends.

  • Oracle announced an influx of marquee cloud customers from various sectors such as financial services, manufacturing, and public sector.

  • Partnership with HID aims to deliver innovative, cost-effective services including cloud nativization in HID's general administration system.

  • Collaboration with Ono Pharma aims to enhance the prediction of risks and probability of trial success through Oracle's Clinical Trial Management System.

  • A significant revamp was done with the Daiwa Institute of Research's order and order analysis infrastructure using Oracle's Autonomous Data Warehouse.

  • Oracle keeps focusing on expansion and efficiency by hiring into growing businesses.

  • 甲骨文的雲業務繼續推動加速增長,證實了公司的收入趨勢。

  • 甲骨文宣佈來自金融服務、製造業和公共部門等各個領域的大型雲客戶湧入。

  • 與HID的合作旨在提供創新、具有成本效益的服務,包括在HID的綜合管理系統中進行雲原生化。

  • 與小野製藥的合作旨在通過甲骨文的臨床試驗管理系統增強對風險和試驗成功概率的預測。

  • 使用甲骨文的自治數據倉庫對大和研究所的訂單和訂單分析基礎設施進行了重大改造。

  • 甲骨文通過招聘成長型企業來一直專注於擴張和效率。

More details: ORACLE CORP JAPAN IR

更多詳情: 甲骨文公司日本 IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:欲了解更多詳情,請訪問投資者關係網站。本文僅供投資者參考,不構成任何投資建議。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論